AQR Arbitrage’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

AQR Arbitrage’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-800,443	Closed	-$27.1M	–	1416
2021 Q2	$27.1M	Buy	+800,443	New	+$20.4M	0.76%	31

AQR Arbitrage's CNST Position: Q3 2021 in Review

AQR Arbitrage sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 800,443 shares — an estimated $27.1M sold.

AQR Arbitrage first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $27.1M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

AQR Arbitrage reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
AQR Arbitrage sold 800,443 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $27.1M.
AQR Arbitrage first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
AQR Arbitrage's Constellation Pharmaceuticals, Inc. position peaked at $27.1M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on AQR Arbitrage's 13F filing for Q3 2021, filed 15 Nov 2021.